Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase
Open Access
- 1 July 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (7), 1480-1489
- https://doi.org/10.1128/aac.38.7.1480
Abstract
The lipopeptide antifungal agents, echinocandins, papulacandins, and pneumocandins, kill Candida albicans by inhibiting glucan synthesis. For this fungus, there is a good correlation of in vitro enzyme inhibition with in vitro assays of MICs. Semisynthetic lipopeptides such as cilofungin, LY303366, L-693,989, and L-733,560 have activity in vivo against Aspergillus infections but appear to be inactive in broth dilution in vitro tests (MICs, > 128 micrograms/ml). To understand how compounds which lack activity in vitro can have good in vivo activity, we monitored the effect of pneumocandins on the morphology of Aspergillus fumigatus and A, flavus strains by light microscopy and electron microscopy and related the changes in growth to inhibition of glucan synthesis. Pneumocandin B0 caused profound changes in hyphal growth; light micrographs showed abnormally swollen germ tubes, highly branched hyphal tips, and many cells with distended balloon shapes. Aspergillus electron micrographs confirmed that lipopeptides produce changes in cell walls; drug-treated germlings showed very stubby growth with thick walls and a conspicuous dark outer layer which was much thicker in the subapical regions. The rest of the hyphal tip ultrastructure was unaffected by the drug, indicating considerable specificity for the primary target. The drug-induced growth alteration produced very compact clumps in broth dilution wells, making it possible to score the morphological effect macroscopically. The morphological changes could be assayed quantitatively by using conventional broth microdilution susceptibility assay conditions. We defined the endpoint as the lowest concentration required to produce the morphological effect and called it the minimum effective concentration to distinguish it from the no-growth endpoints used in MIC determinations. The minimum effective concentration assay was related to inhibition of glucan synthase activity in vitro and may provide a starting point for development of susceptibility testing methods for lipopeptides.Keywords
This publication has 32 references indexed in Scilit:
- Characterization of the 1,3- -glucan synthase of Aspergillus fumigatusJournal of General Microbiology, 1993
- Correlation of cilofungin in vivo efficacy with its activity againstAspergillus fumigatus(1,3)-β-d-glucan synthaseFEMS Microbiology Letters, 1993
- In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) againstAspergillus andCandida speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Anti-Candida Activity and Toxicology of LY121019, a Novel Semisynthetic Polypeptide Antifungal AntibioticAnnals of the New York Academy of Sciences, 1988
- Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019Diagnostic Microbiology and Infectious Disease, 1988
- Nuclear migration in a nud mutant of Aspergillus nidulans is inhibited in the presence of a quantitatively normal population of cytoplasmic microtubules.The Journal of cell biology, 1988
- Echinocandin inhibition of 1,3‐β‐D‐glucan synthase from Candida albicansFEBS Letters, 1984
- The effect of aculeacin A and papulacandin B on morphology and cell wall ultrastructure in Candida albicansCanadian Journal of Microbiology, 1984
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Cell Wall Chemistry, Morphogenesis, and Taxonomy of FungiAnnual Review of Microbiology, 1968